Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Sven H. Loosen, Georg Lurje, Georg Wiltberger, Mihael Vucur, Alexander Koch, Jakob N. Kather, Pia Paffenholz, Frank Tacke, Florian T. Ulmer, Christian Trautwein, Tom Luedde, Ulf P. Neumann, Christoph Roderburg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number0210944
Number of pages17
JournalPLOS ONE
Volume14
Issue number1
DOIs
Publication statusPublished - 17 Jan 2019

Keywords

  • HEPATOCELLULAR-CARCINOMA
  • CIRCULATING MICRORNAS
  • INTRAHEPATIC CHOLANGIOCARCINOMA
  • POTENTIAL BIOMARKERS
  • CANCER
  • EXPRESSION
  • DIAGNOSIS
  • REGULATORS
  • MORTALITY
  • MARKERS

Cite this

Loosen, S. H., Lurje, G., Wiltberger, G., Vucur, M., Koch, A., Kather, J. N., Paffenholz, P., Tacke, F., Ulmer, F. T., Trautwein, C., Luedde, T., Neumann, U. P., & Roderburg, C. (2019). Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma. PLOS ONE, 14(1), [0210944]. https://doi.org/10.1371/journal.pone.0210944